Clinical Trials Directory

Trials / Unknown

UnknownNCT03607396

Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis

Status
Unknown
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
6 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this observational trial is to evaluate the pulmonary function in cystic fibrosis patients that have been treated with inhaled aztreonam lysine comparing the previous 12 months before the treatment and the forward 12 months after initiating the treatment.

Conditions

Timeline

Start date
2018-07-01
Primary completion
2019-07-01
Completion
2019-07-01
First posted
2018-07-31
Last updated
2018-07-31

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT03607396. Inclusion in this directory is not an endorsement.

Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis (NCT03607396) · Clinical Trials Directory